Although previous studies have unequivocally established that the t(6;9) translocation and MYB/MYBL1 fusions are the major genomic hallmarks of ACC [9,11,17,18,19,20], the true frequency and clinical significance of these alterations are still unclear. Here, MYBL1 is linked to adrenal cortex carcinoma.